Lindner Center of HOPE, Staff Psychiatrist
University of Cincinnati College of Medicine, Adjunct Assistant Clinical Professor of Psychiatry
Dr. Ikomi is a psychiatrist who specializes in addictions and co-occurring disorders. He is an Assistant Clinical Professor of Psychiatry and Behavioral Neuroscience at the University of Cincinnati. Dr. Ikomi provides clinical oversight to Lindner Center of HOPE’s outpatient substance abuse treatment program, HOPE Center North. He also provides addiction consults to various inpatient units, long-term care, and outpatient treatment for people suffering from co-occurring substance use disorders, through a range of pharmacotherapies and psychotherapeutic modalities.
Prior to joining Lindner Center of HOPE, Dr. Ikomi was the Medical Director of the Substance Abuse Treatment Unit (SATU) of the Connecticut Mental Health Center (CMHC) for three years; a Yale University affiliated outpatient addiction treatment and research center. His duties at SATU were to oversee the medical management of all patients, medical evaluation of all triage intake assessments, evaluation and treatment disposition of referrals from the New Haven judicial system, and as study physician for the Yale University Research Unit. Additionally, Dr. Ikomi was the SATU Site Training Director for the Yale University Addiction Psychiatry Fellowship Program, and taught residents and medical students.
Dr. Ikomi’s research experience with the Yale University Research Unit involved assisting with development of research protocols and assessment of patient eligibility for clinical trials targeting addiction; specifically, a multi-site randomized controlled study looking at Varenicline for the treatment of heavy drinking smokers, as well as a study looking at the use of Naltrexone for Heavy Drinking in Young Adults. He also recently presented his research about Prevalence and Persistence of Vivid Dreams in Heavy Drinking Smokers receiving Varenicline, at the 2013 Society for Research on Nicotine and Tobacco. Dr. Ikomi’s clinical interests include the use of various pharmacological interventions for patients suffering with substance use disorders, as well as treating substance use disorders in medically compromised patients.
Dr. Ikomi has extensive experience with medical student and residency education. In addition to being the site training director at SATU, he was also the Connecticut Mental Health Center’s (CMHC) addictions outpatient clinic supervisor for Yale University PGY-3 psychiatry residents. Dr. Ikomi was the chair for the division of substance abuse’s monthly clinical case conference as well as the co-chair for the weekly division of substance abuse psychotherapy didactics seminar. He has been an invited guest speaker at the Cleveland Clinic Department of Psychiatry’s Grand Rounds, the Cleveland Psychosomatic Society’s annual conference, the Yale Global Mental Health Initiative conference, and the National Auricular Detoxification Acupuncture international conference.
He completed medical school at the University of Ibadan College of Medicine, in Nigeria, his psychiatry residency at the Cleveland Clinic, and a fellowship in addiction psychiatry at Yale University’s Department of Psychiatry. He remained on faculty at Yale as an Assistant Professor for 3 years before joining Lindner Center of HOPE. He is the current chairman of the News Subcommittee for the Society for Research on Nicotine and Tobacco, Treatment Network committee. He is a 2013 health and disparities travel award winner for the SRNT, as well as 2010 David Agle award winner for best presentation at the Cleveland Psychosomatic Society.
Areas of Specialty / Interest
- Addiction psychopharmacology
- Biological treatments for nicotine cessation
- Substance use disorders in medically compromised patients